BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29026524)

  • 21. The interaction of talin with the cell membrane is essential for integrin activation and focal adhesion formation.
    Chinthalapudi K; Rangarajan ES; Izard T
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10339-10344. PubMed ID: 30254158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Biological Functions and Clinical Applications of Integrins in Cancers.
    Su CY; Li JQ; Zhang LL; Wang H; Wang FH; Tao YW; Wang YQ; Guo QR; Li JJ; Liu Y; Yan YY; Zhang JY
    Front Pharmacol; 2020; 11():579068. PubMed ID: 33041823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the integrin interactome in human disease.
    Vicente-Manzanares M; Sánchez-Madrid F
    Curr Opin Cell Biol; 2018 Dec; 55():17-23. PubMed ID: 30006051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrins as signaling molecules and targets for tumor therapy.
    Ruoslahti E
    Kidney Int; 1997 May; 51(5):1413-7. PubMed ID: 9150452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrins in Vascular Development and Pathology.
    Guerrero PA; McCarty JH
    Adv Pharmacol; 2018; 81():129-153. PubMed ID: 29310797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of Integrins in Gastrointestinal Cancer Metastasis.
    Hou S; Wang J; Li W; Hao X; Hang Q
    Front Mol Biosci; 2021; 8():708779. PubMed ID: 34869579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing.
    Van Waes C
    Head Neck; 1995; 17(2):140-7. PubMed ID: 7558812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can a bulky glycocalyx promote catch bonding in early integrin adhesion? Perhaps a bit.
    Blanchard A
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.
    Fujisaki T; Tanaka Y; Fujii K; Mine S; Saito K; Yamada S; Yamashita U; Irimura T; Eto S
    Cancer Res; 1999 Sep; 59(17):4427-34. PubMed ID: 10485493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of integrin-mediated intercellular adhesion during the interaction of thymocytes with stromal cells expressing VLA-4 and LFA-1 ligands.
    St-Pierre Y; Hugo P; Legault D; Tremblay P; Potworowski EF
    Eur J Immunol; 1996 Sep; 26(9):2050-5. PubMed ID: 8814245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer.
    Das V; Kalyan G; Hazra S; Pal M
    J Cell Physiol; 2018 Jan; 233(1):168-185. PubMed ID: 28120356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular integrins: therapeutic and imaging targets of tumor angiogenesis.
    Rüegg C; Alghisi GC
    Recent Results Cancer Res; 2010; 180():83-101. PubMed ID: 20033379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the Matrix: The Many Non-ECM Ligands for Integrins.
    LaFoya B; Munroe JA; Miyamoto A; Detweiler MA; Crow JJ; Gazdik T; Albig AR
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
    van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C
    Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibronectin and its integrin receptors in cancer.
    Ruoslahti E
    Adv Cancer Res; 1999; 76():1-20. PubMed ID: 10218097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrin affinity modulation.
    Hughes PE; Pfaff M
    Trends Cell Biol; 1998 Sep; 8(9):359-64. PubMed ID: 9728397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting integrins for the control of tumour angiogenesis.
    Akalu A; Cretu A; Brooks PC
    Expert Opin Investig Drugs; 2005 Dec; 14(12):1475-86. PubMed ID: 16307488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Extra-Cellular Matrix-Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors.
    Lorusso G; Rüegg C; Kuonen F
    Front Oncol; 2020; 10():1231. PubMed ID: 32793493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.